MALIGNANT NEOPLASM OF BREAST
Clinical trials for MALIGNANT NEOPLASM OF BREAST explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT NEOPLASM OF BREAST trials appear
Sign up with your email to follow new studies for MALIGNANT NEOPLASM OF BREAST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
DNA vaccine aims to train body to fight breast cancer
⭐️ VACCINE ⭐️ OngoingThis early-stage trial tests whether a DNA vaccine targeting mammaglobin-A (a protein found on breast cancer cells) is safe and can boost the immune system against cancer. About 27 women with ER+, HER2- breast cancer will receive the vaccine while undergoing standard hormone ther…
Matched conditions: MALIGNANT NEOPLASM OF BREAST
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 13:54 UTC
-
Bacteria bombs target Hard-to-Treat tumors in new cancer trial
Disease control OngoingThis early-phase study tests a special bacteria (Clostridium novyi-NT) injected directly into tumors, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors that haven't responded to standard treatments. The goal is to find the safest dose and s…
Matched conditions: MALIGNANT NEOPLASM OF BREAST
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Engineered immune cells take on Hard-to-Treat breast cancer
Disease control OngoingThis early-stage study tests a new two-part treatment for people with advanced breast cancer that has stopped responding to standard therapies. Participants receive a single infusion of their own engineered immune cells (CLBR001) followed by cycles of an antibody drug (ABBV-461).…
Matched conditions: MALIGNANT NEOPLASM OF BREAST
Phase: PHASE1 • Sponsor: Calibr, a division of Scripps Research • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Experimental combo aims to stall tough cancers
Disease control OngoingThis study tests a combination of two drugs, selumetinib and olaparib, in people with advanced or recurrent solid tumors (including breast, digestive, female/male genital, and thyroid cancers). The goal is to find the safest dose and see if it can help control the cancer. Up to 9…
Matched conditions: MALIGNANT NEOPLASM OF BREAST
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
Stress relief before cancer treatment may ease symptoms
Symptom relief OngoingThis study tests whether starting a stress-reduction program before chemotherapy can improve mood, stress, and physical symptoms in women with newly diagnosed breast cancer. About 62 participants will be enrolled at MD Anderson. Researchers will track changes in patient-reported …
Matched conditions: MALIGNANT NEOPLASM OF BREAST
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 03:55 UTC
-
Real-World data reveals how a common breast cancer drug is actually used
Knowledge-focused OngoingThis study looks at medical records from routine care to see how Palbociclib (a targeted therapy) is used in people with a certain type of advanced breast cancer (HR+/HER2-). Researchers want to understand how long patients stay on treatment and whether it delays the need for che…
Matched conditions: MALIGNANT NEOPLASM OF BREAST
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 26, 2026 04:12 UTC
-
Algorithm aims to match tough breast cancers to smarter drug choices
Knowledge-focused TerminatedThis study explores whether a computer algorithm called ENLIGHT can help choose approved drugs for people with advanced breast cancer that has stopped responding to treatment. About 175 adults with triple-negative or hormone-resistant breast cancer will have their tumor tested. B…
Matched conditions: MALIGNANT NEOPLASM OF BREAST
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC
-
New MRI technique aims to sharpen breast cancer detection
Knowledge-focused ENROLLING_BY_INVITATIONThis study is testing a new way to take MRI pictures of the breast using a very low magnetic field. The goal is to see if this method can produce clearer images of breast cancers. About 40 people will take part, and the new images will be compared with standard mammograms, ultras…
Matched conditions: MALIGNANT NEOPLASM OF BREAST
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 18, 2026 12:07 UTC